Psoriasis: current perspectives with an emphasis on treatment.
about
Quality of life in patients with psoriasisCD1a expression in psoriatic skin following treatment with propylthiouracil, an antithyroid thioureyleneSerum TNF-alpha in psoriasis after treatment with propylthiouracil, an antithyroid thioureyleneHLA allele associations and V-beta T-lymphocyte expansions in patients with psoriasis, harboring toxin-producing Staphylococcus aureus.Drug delivery and formulations for the topical treatment of psoriasis.Clinical and pharmacological experience with LJP-394.Pharmacological treatment of the ion transport defect in cystic fibrosis.XP-828L (Dermylex), a new whey protein extract with potential benefit for mild to moderate psoriasis.Selective targeting of T cell subsets: focus on alefacept - a remittive therapy for psoriasis.XP-828l in the treatment of mild to moderate psoriasis: randomized, double-blind, placebo-controlled study.Transition from methotrexate and cyclosporine to other therapies including retinoids, ultraviolet light and biologic agents in the management of patients with psoriasis.The cost-effectiveness and cost of treatment failures associated with systemic psoriasis therapies.Drug-induced psoriasis: an evidence-based overview and the introduction of psoriatic drug eruption probability score.Consistent control of psoriasis by continuous long-term therapy: the promise of biological treatments.Root extract of water dropwort, Oenanthe javanica (Blume) DC, induces protein and gene expression of phase I carcinogen-metabolizing enzymes in HepG2 cells.Psoriasis exacerbation after hormonotherapy in prostate cancer patient-Case report.Topical treatment of psoriasis.Topical delivery for the treatment of psoriasis.Casual or Causal? Two Unique Cases of Hodgkin's Lymphoma: A Case Report and Literature Review.1,4-dihydroxy-2-naphthoic Acid Induces Apoptosis in Human Keratinocyte: Potential Application for Psoriasis Treatment.Leflunomide in the treatment of psoriasis: results of a phase II open trial.The methylation pattern of p16INK4a gene promoter in psoriatic epidermis and its clinical significance.Sulfasalazine and pentoxifylline in psoriasis: a possible safe alternative.Oral pimecrolimus in the treatment of moderate to severe chronic plaque-type psoriasis: a double-blind, multicentre, randomized, dose-finding trial.A new formulation of an occlusive dressing containing betamethasone valerate 0.1% in the treatment of mild to moderate psoriasis.Superiority of a vitamin B12-containing emollient compared to a standard emollient in the maintenance treatment of mild-to-moderate plaque psoriasis.Improved health-related quality of life following a randomized controlled trial of alefacept treatment in patients with chronic plaque psoriasis.Pathogenesis of psoriasis and current challenges.
P2860
Q21245617-B2814FB9-F5A1-4036-B8EA-1ADBD4CCA514Q24791832-CE8EE546-6780-425B-83A0-3A925A2B7D2FQ24803476-D18B3BCA-BA75-4565-8794-D90869CF24E2Q25257329-8A570EA8-BE3F-474C-9B46-D9C80DEEE2D6Q33318104-8D47AA74-FB5E-4614-8B9B-E537A9F1CF84Q33928115-84CEB7D3-8CE2-4922-8600-0A86EFFCADB5Q34104575-94DD7B5F-45D4-4F24-91DA-82BA296D96C4Q34585886-04A67761-9566-40E2-AFFF-5BD197C17683Q34602577-4B00AD6E-1A0E-48C0-96F7-0C34300AFDA1Q34603524-74CEE489-C5F1-4ACD-8F53-5EF13BB1C4D1Q35567825-6C3321C1-678F-42F1-BF5C-A61B19FFCC78Q36391439-D6EA2E90-28BD-4A74-B544-86430EB3DDA1Q36479485-3F764951-8630-4E48-8997-6272E74788D0Q36534231-130E1F29-0083-47E8-89CD-C9543AE27DF3Q36768197-C84D7BAF-BE76-4101-A49C-93770AD84040Q37392381-69528BED-744C-4096-A98B-62AFCDD48C6FQ37766897-C186BC89-7B79-4697-AFED-89BE5376B4A7Q37774344-9B58F421-E1DE-45AE-A44F-480B0D622F19Q38775957-F1FB6F8E-06ED-4A5E-9DED-A3CF3DE95CAFQ40190310-E4C8D25A-1CC0-4C33-A5D3-10D67C4430DEQ42627416-71A021C1-5330-4277-85C2-EF0F827202A0Q45792913-5D09C873-A69A-4725-8451-C0B2E9CC7044Q46361716-CFA716D7-505C-4BEB-AE04-60482F80D09BQ46539253-2F7205D9-4852-4985-8349-75CF0929DA29Q46915226-AC71C580-4AF0-4744-B90E-C1C9EE81541AQ47640941-5E726A6D-80F4-47F1-B4A0-FE4A9B90A3BDQ48011694-97153B7E-D036-4C60-801E-51E8ADCA13AAQ53312205-6A6C2D4C-EA95-43C3-B173-CE1217F60D59
P2860
Psoriasis: current perspectives with an emphasis on treatment.
description
1999 nî lūn-bûn
@nan
1999 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Psoriasis: current perspectives with an emphasis on treatment.
@ast
Psoriasis: current perspectives with an emphasis on treatment.
@en
type
label
Psoriasis: current perspectives with an emphasis on treatment.
@ast
Psoriasis: current perspectives with an emphasis on treatment.
@en
prefLabel
Psoriasis: current perspectives with an emphasis on treatment.
@ast
Psoriasis: current perspectives with an emphasis on treatment.
@en
P1476
Psoriasis: current perspectives with an emphasis on treatment.
@en
P2093
Weinstein GD
P304
P356
10.1016/S0002-9343(99)00284-3
P407
P577
1999-12-01T00:00:00Z